We are live on ! Find out more
BCDA icon

BioCardia
BCDA

16 hedge funds and large institutions have $593K invested in BioCardia in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 12 → 16 (+4)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0.63% more ownership

Funds ownership: 5.24% → 5.88% (+0.63%)

5% less capital invested

Capital invested by funds: $624K → $593K (-$30.6K)

Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$122K
2
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$45.1K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$5.56K
4
Raymond James Financial
Raymond James Financial
Florida
+$4.09K
5
JP Morgan Chase
JP Morgan Chase
New York
+$520

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$47K
2
UBS Group
UBS Group
Switzerland
-$941
3
SS
SBI Securities
Japan
-$4

BCDA Hedge Fund Activity: Q2 2025 in Review

16 of the 7,611 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q2 2025, worth a combined $593K — down 4.9% from $624K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BCDA positions and 0 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was CM Management, adding an estimated $122K. The largest seller was Susquehanna International Group, cutting an estimated $47K.

  • 16 institutional investors held BioCardia (BCDA) as of Q2 2025, up from 12 in Q1 2025.
  • Funds reported $593K of BioCardia stock for Q2 2025, down 4.9% quarter-over-quarter.
  • 4 funds opened new BioCardia positions in Q2 2025 and 0 closed out, a net change of +4 holders.
  • The largest BioCardia buyer in Q2 2025 was CM Management, an estimated $122K added.
  • The largest BioCardia seller in Q2 2025 was Susquehanna International Group, an estimated $47K sold.

Based on aggregated 13F filings for Q2 2025.